A report by David Barboza of the New York Times details how an apparently highly-placed whistleblower in GlaxoSmithKline's China operation sent the head office in London a series of long, well-written memos about illegal sales practices that directors, executives, and auditors chose to ignore.
Entries in Mark Reilly (10)
Here's some non-U.S. news from the past year about anti-corruption enforcement against individuals:
Let's go straight to some news from beyond America's shores during the past year.
A court in China fined UK pharma giant GlaxoSmithKline $490 million Friday following a conviction for bribery.
The British investigator who once worked for GlaxoSmithKline was sentenced to two-and-a-half years in jail for trafficking personal data in China.
Press reports that GlaxoSmithKline fired employees of its China unit in 2001 for paying bribes to government officials could complicate the company's defense of current allegations about illegal sales practices in several countries.
Prosecutors in China have filed formal charges against British private investigator Peter Humphrey and his American wife, the state-controlled Xinhua news agency said Monday.
GlaxoSmith Kline PLC is under investigation by the UK Serious Fraud Office for possible criminal violations, the pharma said Tuesday.
Chinese police Wednesday charged the British former boss of GlaxoSmithKline's China unit and two other company executives with corruption for bribing health officials and doctors.